Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Agriculture and Agri-Food Canada Research Partnership

Université de Montréal

$31,398.00

Cell line bioassay for measuring FSH bioactivity in pregnant mare serum

FY 2007-08

Summary
Cattle breeders need reliable methods to increase production of genetically valuable animals, and to improvehereditary performance traits by selection. The common approach is inducing multiple ovulation in 'donor'cows followed by transfer of the resulting embryos into the wombs of recipient cows. Inducing multipleovulation is expensive and time-consuming, and the results can be highly variable; some cows do not respond to treatment.The cheapest and least labour-intensive drug for inducing multiple ovulation is equine chorionic gonadotropin (eCG). This is a hormone that is produced by the horse placenta during pregnancy, and is purified from horse serum. Some mares produce eCG which has a higher biological activity than that produced by other mares. However, on the horse farm this variability between mares is not taken into account when eCG is collected for use as a drug for inducing multiple ovulation in cattle. This contributes to the variation in activity of batches of commercially available eCG. Further, a large number of horsesare kept for eCG production; this number can be reduced if only the best producing mares are used.To overcome these problems, a rapid method of detecting highly active eCG is required for use at the site of eCG collection. This project aims to develop such a method. We will use an ovarian cell line, which is aculture of cells that divide continually and do not die. Using genetic engineering, we can incorporate into these cells a gene that is turned on when the cells are stimulated by eCG. The higher the activity of the eCG, the greater the expression of this gene will be. Once the gene is turned on, an enzyme is produced that will cause a chemical in the incubation medium to change colour. Thus the activity of eCG can be readily detected by comparing the colour of the cells to a standardized colour chart. This will enable the Canadian pharmaceutical industry to produce a better product, and to reduce the number of horses required to make eCG. This will result in significant economic savings for Canadian cattle breeders
Program
Agriculture and Agri-Food Canada Research Partnership
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
334972-2005
Name nom
Price, Christopher
Department département
Biomédecine vétérinaire
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2007
Competition year année de concours
2005
Award amount
31398
Program id
AAFPJ
Program name en
Agriculture and Agri-Food Canada Research Partnership
Program name fr
Partenariat de recherche d'Agriculture et Agroalimentaire Canada
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
101
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal production and animal primary products
Area of application fr
Production animale et produits animaux primaires
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Partie
2
Nb partie
3
Application title
Cell line bioassay for measuring FSH bioactivity in pregnant mare serum
Keyword
NA
Application summary
Cattle breeders need reliable methods to increase production of genetically valuable animals, and to improvehereditary performance traits by selection. The common approach is inducing multiple ovulation in 'donor'cows followed by transfer of the resulting embryos into the wombs of recipient cows. Inducing multipleovulation is expensive and time-consuming, and the results can be highly variable; some cows do not respond to treatment.The cheapest and least labour-intensive drug for inducing multiple ovulation is equine chorionic gonadotropin (eCG). This is a hormone that is produced by the horse placenta during pregnancy, and is purified from horse serum. Some mares produce eCG which has a higher biological activity than that produced by other mares. However, on the horse farm this variability between mares is not taken into account when eCG is collected for use as a drug for inducing multiple ovulation in cattle. This contributes to the variation in activity of batches of commercially available eCG. Further, a large number of horsesare kept for eCG production; this number can be reduced if only the best producing mares are used.To overcome these problems, a rapid method of detecting highly active eCG is required for use at the site of eCG collection. This project aims to develop such a method. We will use an ovarian cell line, which is aculture of cells that divide continually and do not die. Using genetic engineering, we can incorporate into these cells a gene that is turned on when the cells are stimulated by eCG. The higher the activity of the eCG, the greater the expression of this gene will be. Once the gene is turned on, an enzyme is produced that will cause a chemical in the incubation medium to change colour. Thus the activity of eCG can be readily detected by comparing the colour of the cells to a standardized colour chart. This will enable the Canadian pharmaceutical industry to produce a better product, and to reduce the number of horses required to make eCG. This will result in significant economic savings for Canadian cattle breeders